GENEVA, July 18 -- REGENERON PHARMACEUTICALS, INC. filed a patent application (US2026/010810) for “GLP1R AGONIST-TETHERED GDF8 ANTIBODY CONJUGATES AND USES THEREOF”. With publication no. WO/2026/152012, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....